A novel xanthine dehydrogenase inhibitor (BOF-4272).
Sato
S
S
Otsuka Pharmaceutical Factory, Inc., Tokushima, Japan.
Tatsumi
K
K
Nishino
T
T
D000493:Allopurinol / Q000494:pharmacology; D000818:Animals; D006801:Humans; D019271:Hypoxanthine; D007042:Hypoxanthines / Q000378:metabolism; D007421:Intestine, Small / Q000187:drug effects / Q000378:metabolism*; D007700:Kinetics; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D008168:Lung / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D012016:Reference Values; D013045:Species Specificity; D014227:Triazines / Q000494:pharmacology*; D014503:Urate Oxidase / Q000378:metabolism; D014527:Uric Acid / Q000378:metabolism; D019820:Xanthine; D014968:Xanthine Dehydrogenase / Q000037:antagonists & inhibitors*; D014969:Xanthine Oxidase / Q000378:metabolism; D014970:Xanthines / Q000378:metabolism
D007042:Hypoxanthines; D014227:Triazines; D014970:Xanthines; D019820:Xanthine; D014527:Uric Acid; C072977:BOF 4272; D019271:Hypoxanthine; D000493:Allopurinol; D014968:Xanthine Dehydrogenase; D014969:Xanthine Oxidase; D014503:Urate Oxidase